Disease ID | Disease name | Source of annotation with CDK4 | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
PS155600 | MELANOMA, CUTANEOUS MALIGNANT | ClinVar, OMIM, HUMSAVAR | link to OMIM | 11 | STK11, POT1, BRAF, TERT, PTEN, CDKN2A, MITF, TYR, MC1R, CDK4, XRCC3 |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
T cell receptor signaling pathway | hsa04660 | 6.01 |
Melanoma | hsa05218 | 6.56 |
Bladder cancer | hsa05219 | 7.38 |
Small cell lung cancer | hsa05222 | 6.17 |
Pancreatic cancer | hsa05212 | 6.56 |
Cell cycle | hsa04110 | 5.68 |
Pathways in cancer | hsa05200 | 3.98 |
Viral carcinogenesis | hsa05203 | 5.08 |
p53 signaling pathway | hsa04115 | 6.56 |
Tight junction | hsa04530 | 5.53 |
Non-small cell lung cancer | hsa05223 | 6.88 |
Glioma | hsa05214 | 6.66 |
Chronic myeloid leukemia | hsa05220 | 6.48 |
HTLV-I infection | hsa05166 | 4.59 |
Hepatitis B | hsa05161 | 5.52 |
Measles | hsa05162 | 5.6 |
PI3K-Akt signaling pathway | hsa04151 | 4.21 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Oncogene Induced Senescence | R-HSA-2559585 | 8.03 |
Mitotic G1-G1/S phases | R-HSA-453279 | 5.91 |
Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.51 |
Cellular Senescence | R-HSA-2559583 | 5.7 |
G1 Phase | R-HSA-69236 | 7.73 |
Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.7 |
Meiotic recombination | R-HSA-912446 | 7.25 |
Cellular responses to stress | R-HSA-2262752 | 4.56 |
Cell Cycle | R-HSA-1640170 | 3.89 |
S Phase | R-HSA-69242 | 6.02 |
Meiosis | R-HSA-1500620 | 6.59 |
Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.77 |
Cell Cycle, Mitotic | R-HSA-69278 | 4.16 |
Chromatin organization | R-HSA-4839726 | 5.19 |
Cyclin D associated events in G1 | R-HSA-69231 | 7.73 |
Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.34 |
RMTs methylate histone arginines | R-HSA-3214858 | 7.49 |
Ubiquitin-dependent degradation of Cyclin D1 | R-HSA-69229 | 7.34 |
Developmental Biology | R-HSA-1266738 | 3.48 |
Chromatin modifying enzymes | R-HSA-3247509 | 5.19 |
GO term | GO ID | GO IC |
---|---|---|
kinase regulator activity | GO:0019207 | 4.5 |
purine ribonucleoside triphosphate binding | GO:0035639 | 2.22 |
macromolecular complex binding | GO:0044877 | 2.61 |
binding | GO:0005488 | 0.18 |
cyclin-dependent protein serine/threonine kinase activity | GO:0004693 | 6.21 |
molecular function regulator | GO:0098772 | 2.51 |
heterocyclic compound binding | GO:1901363 | 1.06 |
nucleoside phosphate binding | GO:1901265 | 1.96 |
nucleoside binding | GO:0001882 | 2.21 |
cyclin-dependent protein serine/threonine kinase regulator activity | GO:0016538 | 6.41 |
cyclin-dependent protein kinase activity | GO:0097472 | 6.21 |
nucleotide binding | GO:0000166 | 1.96 |
protein serine/threonine kinase activity | GO:0004674 | 3.64 |
transferase activity | GO:0016740 | 1.95 |
purine nucleoside binding | GO:0001883 | 2.22 |
protein kinase activity | GO:0004672 | 3.27 |
protein complex binding | GO:0032403 | 3.09 |
purine nucleotide binding | GO:0017076 | 2.19 |
ATP binding | GO:0005524 | 2.43 |
kinase activity | GO:0016301 | 2.93 |
cyclin binding | GO:0030332 | 6.74 |
protein kinase regulator activity | GO:0019887 | 4.6 |
enzyme regulator activity | GO:0030234 | 2.85 |
ribonucleoside binding | GO:0032549 | 2.22 |
small molecule binding | GO:0036094 | 1.89 |
catalytic activity | GO:0003824 | 1.05 |
adenyl nucleotide binding | GO:0030554 | 2.4 |
carbohydrate derivative binding | GO:0097367 | 2.03 |
organic cyclic compound binding | GO:0097159 | 1.05 |
phosphotransferase activity, alcohol group as acceptor | GO:0016773 | 3.08 |
adenyl ribonucleotide binding | GO:0032559 | 2.41 |
protein binding | GO:0005515 | 0.46 |
transferase activity, transferring phosphorus-containing groups | GO:0016772 | 2.77 |
purine ribonucleotide binding | GO:0032555 | 2.2 |
purine ribonucleoside binding | GO:0032550 | 2.22 |
ribonucleotide binding | GO:0032553 | 2.19 |